References

1. R Doglia (2017). The need of dermatologists, psychiatrists and psychologists joint care in psychodermatology.
2. K Paucar (2018). Relación bidireccional de las patologías cutáneas con los trastornos mentales.
3. Katlein Franca,Anna Chacon,Jennifer Ledon,Jessica Savas,Keyvan Nouri (2013). Pyschodermatology: a trip through history.
4. S Yadav,T Narang,M Kumaran (2013). Psychodermatology: A comprehensive review.
5. Bruce Mcewen (2012). Brain on stress: How the social environment gets under the skin.
6. Petra Arck,Andrzej Slominski,Theoharis Theoharides,Eva Peters,Ralf Paus (2006). Neuroimmunology of Stress: Skin Takes Center Stage.
7. Ying Chen,John Lyga (2014). Brain-Skin Connection: Stress, Inflammation and Skin Aging.
8. J Escalas,A Guerra,M Rodríguez-Cerdeira (2010). Tratamiento con psicofármacos de los trastornos psicodermatológicos.
9. Jan-Marino Ramirez (2014). The Integrative Role of the Sigh in Psychology, Physiology, Pathology, and Neurobiology.
10. K Sayar,O Köse,S Ebrinç,M Şetin (2001). Hopelessness, Depression and Alexithymia in Young Turkish Soldiers Suffering from Alopecia areata.
11. H Richards,D G Fortune,C Griffiths,C Main (2005). Alexithymia in patients with psoriasis: clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20.
12. G Maniaci,M Epifanio,M Marino,S Amoroso (2006). The presence of alexithymia investigated by the TAS-20 in chronic urticaria patients: A preliminary report.
13. A Picardi,P Pasquini,M Cattaruzza,P Gaetano,C Melchi,G Baliva (2003). Stressfull life events, social support, attachment security and alexithymia in vitíligo. A case-control study.
14. Amanda Mosini,Marcelo Saad,Camilla Braghetta,Roberta Medeiros,Mario Peres,Frederico Leão (2019). Neurophysiological, cognitive-behavioral and neurochemical effects in practitioners of transcendental meditation - A literature review.
15. Madhulika Gupta,Aditya Gupta,Charles Ellis,Caroline Koblenzer (2005). Psychiatric Evaluation of the Dermatology Patient.
16. A Lavda,T L Webb,A Thompson (2012). A meta-analysis of the effectiveness of psychological interventions for adults with skin conditions.
17. Philip Shenefelt (2010). Psychological interventions in the management of common skin conditions.
18. Richard Fried (2013). Nonpharmacologic Management of Psychodermatologic Conditions.
19. Philip Shenefelt (2000). Hypnosis in Dermatology.
20. Liana Schreiber,Brian Odlaug,Jon Grant (2011). Diagnosis and treatment of trichotillomania.
21. Tiffany Field,Michael Peck,Scott Krugman,Tammy Tuchel,Saul Schanberg,Cynthia Kuhn,Iris Burman (1998). Burn Injuries Benefit from Massage Therapy.
22. Giovanni Fava,Fiammetta Cosci,Nicoletta Sonino (2017). Current Psychosomatic Practice.
23. Heike Gerger,Michaela Hlavica,Jens Gaab,Thomas Munder,Jürgen Barth (2015). Does It Matter Who Provides Psychological Interventions for Medically Unexplained Symptoms? A Meta-Analysis.
24. Allan Abbass,Stephen Kisely,Kurt Kroenke (2009). Short-Term Psychodynamic Psychotherapy for Somatic Disorders.
25. Mechthild Hartmann,Eva Bäzner,Beate Wild,Ivan Eisler,Wolfgang Herzog (2010). Effects of Interventions Involving the Family in the Treatment of Adult Patients with Chronic Physical Diseases: A Meta-Analysis.
26. Giovanni Fava,Jenny Guidi,Chiara Rafanelli,Nicoletta Sonino (2015). The Clinical Inadequacy of Evidence-Based Medicine and the Need for a Conceptual Framework Based on Clinical Judgment.
27. Cody Connor (2017). Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines.
28. Sheng-Min Wang,Jung-Bum Kim,Jeong Sakong,Ho-Suk Suh,Kang Oh,Jong-Min Woo,Sang-Woo Yoo,Sang Lee,Sang-Yeol Lee,Se-Won Lim,Seong Cho,Ik-Seung Chee,Jeong-Ho Chae,Jin Hong,Kyoung-Uk Lee (2016). The Efficacy and Safety of Clonazepam in Patients with Anxiety Disorder Taking Newer Antidepressants: A Multicenter Naturalistic Study.
29. M Kavan,G Elsasser,E Barone (2009). Multiple Somatic Complaints (Generalized Anxiety Disorder).
30. Robert Bielski,Anjana Bose,Chung-Chi Chang (2005). A Double-Blind Comparison of Escitalopram and Paroxetine in the Long-Term Treatment of Generalized Anxiety Disorder.
31. Jonathan Davidson,Anjana Bose,Andrew Korotzer,Hongjie Zheng (2004). Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study.
32. Jonathan Davidson,Anjana Bose,Qin Wang (2005). Safety and Efficacy of Escitalopram in the Long-Term Treatment of Generalized Anxiety Disorder.
33. Stefan Leucht,Werner Steimer,Stefan Kreuz,Dorothee Abraham,Paul Orsulak,Werner Kissling (2001). Doxepin Plasma Concentrations: Is There Really a Therapeutic Range?.
34. Ajeet Singh,Chad Bousman,Chee Ng,Keith Byron,Michael Berk (2013). Psychomotor depressive symptoms may differentially respond to venlafaxine.
35. Thomas Baghai,Daniela Eser,Hans-Jürgen Möller (2008). Effects of different antidepressant treatments on the core of depression.
36. Andrea Cipriani,Toshiaki Furukawa,Georgia Salanti,John Geddes,Julian Higgins,Rachel Churchill,Norio Watanabe,Atsuo Nakagawa,Ichiro Omori,Hugh Mcguire,Michele Tansella,Corrado Barbui (2009). Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.
37. Levin,C Gieler,U (2013). Delusions of parasitosis.
38. Viraat Patel,John Koo (2015). Delusions of parasitosis; suggested dialogue between dermatologist and patient.
39. J Koo,A Lebwohl (2001). Psychodermatology: the mind and skin connection.
40. S Flann,J Shotbolt,B Kessel,D Vekaria,R Taylor,A Bewley,A Pembroke (2010). Three cases of delusional parasitosis caused by dopamine agonists.
41. M Kölle,P Lepping,J Kassubek,C Schönfeldt-Lecuona,R Freudenmann (2010). Delusional Infestation Induced by Piribedil Add-On in Parkinson's Disease.
42. C L Marshall,V Williams,C Ellis,R E Taylor,A Bewley (2017). Delusional infestation may be caused by recreational drug usage in some patients, but they may not disclose their habit.
43. Cynthia Lorenzo,John Koo (2004). Pimozide in Dermatologic Practice.
44. Roland Freudenmann,Peter Lepping (2008). Second-Generation Antipsychotics in Primary and Secondary Delusional Parasitosis.
45. Markus Huber,Peter Lepping,Roger Pycha,Martin Karner,Josef Schwitzer,Roland Freudenmann (2011). Delusional infestation: treatment outcome with antipsychotics in 17 consecutive patients (using standardized reporting criteria).
46. Wei-Lieh Huang,Li-Ren Chang (2013). Aripiprazole in the Treatment of Delusional Parasitosis With Ocular and Dermatologic Presentations.
47. B Ladizinski,K Busse,T Bhutani,J Koo (2010). Aripiprazole as a viable alternative for treating delusions of parasitosis.
48. Maarten Bak,Annemarie Fransen,Jouke Janssen,Jim Van Os,Marjan Drukker (2014). Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis.
49. Nir Barak,Yaffa Beck,Joseph Albeck (2016). A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Betahistine to Counteract Olanzapine-Associated Weight Gain.
50. Nir Barak,Yaffa Beck,Joseph Albeck (2016). Betahistine decreases olanzapine-induced weight gain and somnolence in humans.
51. Jiamei Lian,Xu-Feng Huang,Nagesh Pai,Chao Deng (2016). Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.
52. S Wong,A Bewley (2011). Patients with delusional infestation (delusional parasitosis) often require prolonged treatment as recurrence of symptoms after cessation of treatment is common: an observational study.
53. Vlasios Brakoulias (2015). Managing obsessive compulsive disorder.
54. L Ost,E Riise,G Wergeland,B Hansen,G Kvale (2016). Cognitive behavioral and pharmacological treatments of OCD in children: a systematic review and meta-analysis.
55. Bethany Wootton (2016). Remote cognitive–behavior therapy for obsessive–compulsive symptoms: A meta-analysis.
56. J Goulding (2015). <i>N</i> -acetylcysteine in trichotillomania: further thoughts.
57. Jon Grant,Brian Odlaug,Suck Won Kim (2009). N-Acetylcysteine, a Glutamate Modulator, in the Treatment of Trichotillomania.
58. D Özcan,D Seçkin (2016). N‐Acetylcysteine in the treatment of trichotillomania: remarkable results in two patients.
59. M Taylor,K Bhagwandas (2014). <i>N</i> ‐acetylcysteine in trichotillomania: a panacea for compulsive skin disorders?.
60. Rachel Rothbart,Taryn Amos,Nandi Siegfried,Jonathan Ipser,Naomi Fineberg,Samuel Chamberlain,Dan Stein (2013). Pharmacotherapy for trichotillomania.
61. Daniel Ring (2010). Inexpensive Solution for Habit-Tic Deformity.
62. C Bowen,J Bidinger,C Hivnor,A Hoover,J Henning (2014). Allergic contact dermatitis to 2-octyl cyanoacrylate.
63. Mark Davis,Michael Stuart (2016). Severe Allergic Contact Dermatitis to Dermabond Prineo, a Topical Skin Adhesive of 2-Octyl Cyanoacrylate Increasingly Used in Surgeries to Close Wounds.
64. Sébastien Lefèvre,Aude Valois,François Truchetet (2016). Allergic contact dermatitis caused by Dermabond^®.
65. Chai Lee,Robert Accordino,Josephine Howard,John Koo (2008). Psychopharmacology in dermatology.